Thai Cancer Anemia Survey in Chulalongkorn Hospital
- Conditions
- CancerAnemia
- Interventions
- Other: Adult Cancer Patients
- Registration Number
- NCT01018043
- Lead Sponsor
- Janssen-Cilag Ltd.,Thailand
- Brief Summary
The purpose of this study is to create a large Thailand database documenting the severity of anemia and its management in the cancer population.
- Detailed Description
Thai Cancer Anemia Study (TCAS) is a prospective survey that will track anemia management in an adult cancer population. This survey is not intended to interfere with standard medical practices for handling anemia. Information on laboratory values including target and achieved hemoglobin (Hb) levels during chemotherapy cycles, use of blood transfusions, iron supplementation, and epoetin will be collected in addition to information on cancer status and treatment. Data on the level that triggers clinicians to decide on the need for anemia therapy will also be collected. Each patient included in the survey will be followed for six months. Observational Study - No investigational drug administered
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 264
- Patients with cancer
- None
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description 001 Adult Cancer Patients Adult Cancer Patients Tracking anemia management in Adult Cancer Patients
- Primary Outcome Measures
Name Time Method Number of patients that have anemia during cancer therapy 6 months
- Secondary Outcome Measures
Name Time Method Characteristic of each patients example treatment duration,type and chemotherapy using, grade of anemia 6 months